NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,905 | +3.5% | 11,594 | 0.0% | 0.00% | – |
| Q2 2023 | $6,669 | -18.2% | 11,594 | 0.0% | 0.00% | – |
| Q1 2023 | $8,149 | -68.9% | 11,594 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $26,202 | -88.0% | 11,594 | -83.0% | 0.00% | -83.3% |
| Q3 2022 | $219,000 | -20.9% | 68,388 | -6.2% | 0.01% | -25.0% |
| Q2 2022 | $277,000 | -29.9% | 72,888 | -0.5% | 0.01% | -11.1% |
| Q1 2022 | $395,000 | -60.0% | 73,281 | +0.3% | 0.01% | -60.9% |
| Q4 2021 | $987,000 | +235.7% | 73,055 | +346.5% | 0.02% | +187.5% |
| Q3 2021 | $294,000 | -93.5% | 16,362 | -93.9% | 0.01% | -96.0% |
| Q4 2020 | $4,532,000 | – | 266,559 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |